Warning: The NCBI web site requires JavaScript to function. more...
PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture.
Pearson GW, Hunter T.
Breast Cancer Res. 2009;11(3):R29. Epub 2009 May 20.
Related citations
Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W, Pew T, Zou M, Pang D, Conzen SD.
J Biol Chem. 2005 Feb 11;280(6):4117-24. Epub 2004 Dec 7.
Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA, Vellon L, Colomer R, Lupu R.
Int J Cancer. 2005 May 20;115(1):19-35.
Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.
Wang X, Li N, Li H, Liu B, Qiu J, Chen T, Cao X.
Clin Cancer Res. 2005 Oct 15;11(20):7545-53.
Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
Cancer Res. 2001 Sep 15;61(18):6747-54.
Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast.
Chan KC, Knox WF, Gee JM, Morris J, Nicholson RI, Potten CS, Bundred NJ.
Cancer Res. 2002 Jan 1;62(1):122-8.
p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades.
Sharma GD, He J, Bazan HE.
J Biol Chem. 2003 Jun 13;278(24):21989-97. Epub 2003 Mar 26.
Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.
Whyte J, Bergin O, Bianchi A, McNally S, Martin F.
Breast Cancer Res. 2009;11(5):209. Epub . Review.
Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.
Lønne GK, Masoumi KC, Lennartsson J, Larsson C.
J Biol Chem. 2009 Nov 27;284(48):33456-65. Epub 2009 Oct 15.
BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation.
Anderson LR, Sutherland RL, Butt AJ.
Oncogene. 2010 Jan 28;29(4):527-38. Epub 2009 Nov 2.
Real-time imaging reveals that noninvasive mammary epithelial acini can contain motile cells.
J Cell Biol. 2007 Dec 31;179(7):1555-67.
A bidirectional "alpha(v)beta(3) integrin-ERK1/ERK2 MAPK" connection regulates the proliferation of breast cancer cells.
Vellon L, Menendez JA, Lupu R.
Mol Carcinog. 2006 Oct;45(10):795-804.
HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway.
Kakazu A, Chandrasekher G, Bazan HE.
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3485-92.
A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
Menendez JA, Vellon L, Mehmi I, Teng PK, Griggs DW, Lupu R.
Oncogene. 2005 Jan 27;24(5):761-79.
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
Int J Oncol. 2004 Mar;24(3):591-608.
Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2.
Chen J, Deng F, Singh SV, Wang QJ.
Cancer Res. 2008 May 15;68(10):3844-53.
Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH, Bianchi F, Voshol J, Bonenfant D, Oakeley EJ, Hynes NE.
Cancer Res. 2010 May 15;70(10):4151-62. Epub 2010 May 11.
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE.
Breast Cancer Res. 2007;9(5):R63.
Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells.
Glotin AL, Calipel A, Brossas JY, Faussat AM, Tréton J, Mascarelli F.
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4614-23.
Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells.
Moon Y, Yang H, Kim YB.
Toxicol Appl Pharmacol. 2007 Sep 1;223(2):155-63. Epub 2007 May 21.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on